SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Good Cancer research Bio company?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (43)10/5/1996 5:19:00 PM
From: burner   of 76
 
Marty,
A couple of Canadian biotech stocks are XLX:TSE, IUT:TSE(also on NASDAQ; I think IUTMF) and one that I particularly like NVO:VSE. These are stocks that specialize in cancer reserarch or detection.
Xillix has a thread going and a lot else going for it! It is pursuing a NASDAQ listing. Novopharm is a wholly owned subsidiary of Novopharm Ltd. which is a privately owned generic pharmaceutical giant in Canada. There is sone speculation that the parent company may one day use the listing of Novopharm biotech (NVO) to facilitate going public. NVO is trading around $2.00 CDN and is definitely on the upswing. Personally I have been buying since it was trading at fifty cents and am still interested in putting it in my Registered Retirement Plan anywhere under $!.70
Immutec has also had some nice movement and although I have none I remain interested, particulary since it has U.S. exposure.
Try xillix.com
You can reach Novopaharm's Stacy Jurchison (IR) @1-800-268-4127 Ext#5165
Dan Byrne
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext